Breast cancer in the 21st century
25 Jul 2016
Breast cancer in the 21st century
Educational online dialogues for cancer clinicians
Updates in prostate and bladder cancer therapy
Review of olaparib for ovarian cancer
Lung cancer immunotherapy
Best of ASCO 2016: Introduction and aims
'Other' targets in lung cancer
Developments in gastrointestinal tumour treatment
Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists
Towards deciphering the functional genetics and neo-antigenic landscape in melanoma
Polycomb repressors and epigenetic therapy
DNA repair and mutations as targets for personalised therapy